An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

Summary

The primary aim of this study is to assess whether naltrexone as a monotherapy is effective in treating Attention Deficit Hyperactivity Disorder (ADHD) in adults. Medications that increase dopamine are often effective in treating ADHD in adults. Since naltrexone is a kappa opioid receptor antagonist, it increases dopamine in the brain. We predict that naltrexone as a monotherapy will be effective for ADHD symptoms in adults with ADHD.

Timeline

Start

2013-11

Primary completion

2016-06

Completion

2016-06

Drugs

Indications